We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 173 results
  1. mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development

    Triggered by the ground-breaking finding that ketamine exerts robust and rapid-acting antidepressant effects in patients with treatment-resistant...

    Article 30 January 2023
  2. Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice

    Cognitive impairment is a core feature of schizophrenia and is poorly addressed by currently available medication. This is partly because the...

    Oana-Daniela Dormann, Niklas Schuelert, Holger Rosenbrock in Translational Psychiatry
    Article Open access 06 May 2023
  3. Rapastinel alleviates the neurotoxic effect induced by NMDA receptor blockade in the early postnatal mouse brain

    Rapastinel is a novel psychoactive substance that acts as an N-methyl-D-aspartate-receptor (NMDAR) agonist and triggers antidepressant- and...

    Andrei-Nicolae Vasilescu, Anne Mallien, ... Dragos Inta in European Archives of Psychiatry and Clinical Neuroscience
    Article 13 August 2020
  4. Pre- and postsynaptic signatures in the prelimbic cortex associated with “alcohol use disorder” in the rat

    The transition to alcohol use disorder (AUD) involves persistent neuroadaptations in executive control functions primarily regulated by the medial...

    Ana Domi, Davide Cadeddu, ... Louise Adermark in Neuropsychopharmacology
    Article Open access 16 May 2024
  5. Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions

    Schizophrenia is a mental illness associated with an array of symptoms that often result in disability. The primary treatments for schizophrenia are...

    Joshua T. Kantrowitz in CNS Drugs
    Article 15 October 2021
  6. Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics

    Psychedelics, also known as classical hallucinogens, have been investigated for decades due to their potential therapeutic effects in the treatment...

    Alaina M. Jaster, Javier González-Maeso in Molecular Psychiatry
    Article 27 September 2023
  7. The neuropsychopharmacology of acetyl-L-carnitine (LAC): basic, translational and therapeutic implications

    Mitochondrial metabolism can contribute to nuclear histone acetylation among other epigenetic mechanisms. A central aspect of this signaling pathway...

    Benedetta Bigio, Shofiul Azam, ... Carla Nasca in Discover Mental Health
    Article Open access 02 January 2024
  8. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression

    Therapeutic deficiencies with monoaminergic antidepressants invites the need to identify and develop novel rapid-acting antidepressants. Hitherto,...

    Susan Ling, Felicia Ceban, ... Roger S. McIntyre in CNS Drugs
    Article 17 November 2021
  9. Assessment of Innovative Pharmacological Targets in Schizophrenia

    Purpose of review

    Schizophrenia is a disorder with an approximate prevalence of 1% associated with great impairments in daily life functioning and...

    Teresa Reynolds de Sousa, Marta Ribeiro, Filipa Novais in Current Treatment Options in Psychiatry
    Article Open access 13 July 2024
  10. The mGlu2/3 antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu2 activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmoset

    We have recently shown that activation of metabotropic glutamate 2 (mGlu 2 ) receptors through positive allosteric modulation and orthosteric...

    Stephen G. Nuara, Adjia Hamadjida, ... Philippe Huot in Journal of Neural Transmission
    Article 24 April 2020
  11. Operant self-stimulation of thalamic terminals in the dorsomedial striatum is constrained by metabotropic glutamate receptor 2

    Dorsal striatal manipulations including stimulation of dopamine release and activation of medium spiny neurons (MSNs) are sufficient to drive...

    Kari A. Johnson, Lucas Voyvodic, ... David M. Lovinger in Neuropsychopharmacology
    Article 29 January 2020
  12. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

    Neuropsychiatric disorders are multifactorial disorders with diverse aetiological factors. Identifying treatment targets is challenging because the...

    Thian-Sze Wong, Guangzhi Li, ... Yang Du in Signal Transduction and Targeted Therapy
    Article Open access 03 May 2023
  13. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status

    The efficacy of standard antidepressants is limited for many patients with mood disorders such as major depressive disorder (MDD) and bipolar...

    Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate Jr. in CNS Drugs
    Article 26 April 2021
  14. Preventing incubation of drug craving to treat drug relapse: from bench to bedside

    In 1986, Gawin and Kleber reported a progressive increase in cue-induced drug craving in individuals with cocaine use disorders during prolonged...

    **aoxing Liu, Kai Yuan, ... Ying Han in Molecular Psychiatry
    Article 16 January 2023
  15. Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia

    According to the adenosine hypothesis of schizophrenia, the classically associated hyperdopaminergic state may be secondary to a loss of function of...

    Marta Valle-León, Luis F. Callado, ... Francisco Ciruela in Neuropsychopharmacology
    Article Open access 03 October 2020
  16. Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches

    Schizophrenia is a major mental illness associated with profound disability. Current treatments for schizophrenia (antipsychotics) all have a similar...

    Joshua T. Kantrowitz in CNS Drugs
    Article 11 August 2020
  17. Perinatal THC exposure via lactation induces lasting alterations to social behavior and prefrontal cortex function in rats at adulthood

    Cannabis is the world’s most widely abused illicit drug and consumption amongst women during and surrounding the period of pregnancy is increasing....

    Andrew F. Scheyer, Milene Borsoi, ... Olivier J. J. Manzoni in Neuropsychopharmacology
    Article 19 May 2020
  18. The role of hippocampus in memory reactivation: an implication for a therapeutic target against opioid use disorder

    Purpose of the review

    The abuse of opioids induces many terrible problems in human health and social stability. For opioid-dependent individuals,...

    Zhong-hua Dai, **ng Xu, ... **g Liang in Current Addiction Reports
    Article 19 February 2022
Did you find what you were looking for? Share feedback.